InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Bizzari Jean-Pierre, Director. Director active across 3 companies, notably Halozyme Therapeutics, INC.. Aggregated, 12 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €1.2m. History available since 5 May 2021. The latest transaction was disclosed on 1 June 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bizzari Jean-Pierre
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
3,135 股Common StockSEC:0001104659-26-075281:0
45,000 股0Common SharesSEC:0001628280-26-040488:0
12,600 股@ US$3.0836.7% 占其流量Common SharesSEC:0001628280-26-040488:1
12,600 股@ US$3.5842.7% 占其流量Common SharesSEC:0001628280-25-031891:0
1,045 股0Common StockSEC:0001104659-25-057806:0
40,000 股0Common SharesSEC:0001628280-25-029735:0
6,995 股@ US$2.8920.7% 占其流量Common SharesSEC:0001628280-24-028992:0
40,000 股0Common SharesSEC:0001628280-24-028355:0
8,065 股0Common StockSEC:0001415889-23-007687:0
6,206 股0Restricted Stock UnitsSEC:0001179110-22-002906:0
35,000 股@ US$41.013100.0% 占其流量Common StockSEC:0001179110-21-008418:0
5,230 股0Restricted Stock UnitsSEC:0001179110-21-004969:0
12 条申报中的 12 条
About Bizzari Jean-Pierre
Jean-Pierre Bizzari is a Director at Halozyme Therapeutics, Inc. He brings valuable expertise in corporate governance and business strategy. His role involves overseeing the company's operations and contributing to strategic decision-making. With a strong background in the biopharmaceutical sector, he is involved in developing innovative solutions to improve patient health.
